← Back to Search

0.5% ropivacaine for Femur Fractures

Phase 4
Waitlist Available
Led By He C S, MD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 0, 8, 16, 24, 36, 48, and 72 hours postoperatively
Awards & highlights

Study Summary

This trial is testing whether a pain-blocking injection during surgery can help control pain better than a saline solution injection in people with broken femurs.

Eligible Conditions
  • Femur Fracture

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 0, 8, 16, 24, 36, 48, and 72 hours postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 0, 8, 16, 24, 36, 48, and 72 hours postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in postoperative pain at 72 hours
Secondary outcome measures
Narcotic usage

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Hematoma blockExperimental Treatment1 Intervention
Fracture site injection of 20 mL of 0.5% ropivacaine with an 18-gauge needle (150 mm length).
Group II: Normal saline injectionPlacebo Group1 Intervention
Fracture site injection of 20ml of normal saline.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ropivacaine
FDA approved

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
430 Previous Clinical Trials
634,403 Total Patients Enrolled
He C S, MDPrincipal InvestigatorUniversity of Cincinnati
~15 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top